Europe Approves New Roche Holding AG Arthritis Drug
Published: Jan 21, 2009
ZURICH/LONDON, Jan 21 (Reuters) - Roche Holding AG has won final approval to sell its new rheumatoid arthritis drug, RoActemra, in Europe, the Swiss drugmaker said on Wednesday.